Skip to main content

Table 8 Additional myocardial morphology comparison: hematological malignancies (HMs) vs solid tumors (STs)

From: Differential cardiac impacts of hematological malignancies and solid tumors: a histopathological and biomarker study

 

HM (n=92)

ST (n=36)

p Value

Cytoplasmic Vacuoles

  

0.058

0 (absent)

83 (90%)

36 (100%)

 

1 (mild)

9 (9.8%)

0 (0%)

 

2 (moderate/severe)

0 (0%)

0 (0%)

 

Nuclear Atypia

  

0.9

0 (absent)

26 (28%)

10 (29%)

 

1 (mild)

54 (59%)

22 (63%)

 

2 (moderate/severe)

12 (13%)

3 (8.6%)

 

Lipofuscin Deposition

  

0.5

0 (absent)

1 (1.1%)

0 (0%)

 

1 (mild/moderate)

56 (61%)

18 (50%)

 

2 (severe)

35 (38%)

18 (50%)

 

Myocyte apposition

  

0.011

0 (absent)

1 (1.1%)

0 (0%)

 

1 (mild/moderate)

79 (86%)

24 (67%)

 

2 (severe)

12 (13%)

12 (33%)

 
  1. The tissue samples that met the acceptable criteria for histologic analysis of specific features were limited, resulting in smaller sample sizes
Back to article page

Cardio-Oncology

ISSN: 2057-3804

Contact us